肝康颗粒对肝纤维化大鼠tgf-β1 ha iv型胶原影响的实验研究-experimental study on the effect of gankang granules on tgf - β 1 ha type iv collagen in rats with hepatic fibrosis.docxVIP

下载本文档

4
0
约3.17万字
约 41页
2018-05-30 发布于上海
举报
版权申诉

肝康颗粒对肝纤维化大鼠tgf-β1 ha iv型胶原影响的实验研究-experimental study on the effect of gankang granules on tgf - β 1 ha type iv collagen in rats with hepatic fibrosis.docx

1、原创力文档（book118）网站文档一经付费（服务费），不意味着购买了该文档的版权，仅供个人/单位学习、研究之用，不得用于商业用途，未经授权，严禁复制、发行、汇编、翻译或者网络传播等，侵权必究。。
2、本站所有内容均由合作方或网友上传，本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺！文档内容仅供研究参考，付费前请自行鉴别。如您付费，意味着您自己接受本站规则且自行承担风险，本站不退款、不进行额外附加服务；查看《如何避免下载的几个坑》。如果您已付费下载过本站文档，您可以点击这里二次下载。
3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等，请点击“版权申诉”（推荐），也可以打举报电话：400-050-0827(电话支持时间：9:00-18:30)。
4、该文档为VIP文档，如果想要下载，成为VIP会员后，下载免费。
5、成为VIP后，下载本文档将扣除1次下载权益。下载后，不支持退款、换文档。如有疑问请联系我们。
6、成为VIP后，您将拥有八大权益，权益包括：VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
7、VIP文档为合作方或网友上传，每下载1次，网站将根据用户上传文档的质量评分、类型等，对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档

肝康颗粒对肝纤维化大鼠tgf-β1 ha iv型胶原影响的实验研究-experimental study on the effect of gankang granules on tgf - β 1 ha type iv collagen in rats with hepatic fibrosis

＜0.01);Comparedwithpathologicalmodelgroup,andGankangkeliparticlesinlarge-doseandsmall-dosegroupandDahuangzhechongwangroupareserumtypeHAlevelofsignificantly,thesignificantstatisticallysignificantdifference(P＜0.01).2.TheratliverfibrosisserumtypeIVcollagenindexshows:comparedwithnormalcontrolgroup,pathologicalmodelrats,serumtypeIVcollagenlevelenhancedmarkedly,significantstatisticallysignificantdifference(P＜0.01);Comparedwithpathologicalmodelgroup,andGankangkeliparticlesinlarge-dosegroupandsmall-dosegroupofserumtypeIVcollagenlevelsignificantly,thedifferencesaresignificant﹙P＜0.05﹚.3.Hepaticfibrosishepaticpathologyshowed:Gankangkelicansignificantlyreducetheliverfibrosisdegreeofliverinflammationandfibrosis.4.Ratweightandliverindexmeasuredresultsshowed:Gankangkelicanincreaseliverweightofrats,reducedtheliverindex.5.ImmunohistochemicaldetectionofTGF-β1andHAtypeIV-Cexpressiondisplayed:Comparedwiththenormalcontrolgroup,pathologicalmodelgroupinratlivertissueTGF-β1andtypeHA,IVcollagenexpressionenhanced,astatisticallysignificantdifference(P＜0.05);Comparedwithpathologicalmodelgroup,andGankangkeliparticlesinlarge-doseandDahuangzhechongwangroupTGF-β1andHAtypeIVcollagenexpressionareobviouslydrop,significantstatisticallysignificantdifference(P＜0.01);AndGankangkeligroupcomparedparticlesaresmall-doses,Gankangkeliparticlesinlarge-dosegroupTGF-β1dosegroupofHAtypeIVcollagenandareobviouslydrop,significantstatisticallysignificantdifference(P＜0.01).Conclusion:GankangkelicaneffectivelyreduceserumHAtypeIVcollagenlevelofratliversinusoidalendothelialcellsreducetheextentofthedamage,andportalhypertension,liverfibrosis,showingbetterprotecttheliver,hepaticfibrosis;GankangkelicouldinhibitliverTGF-β1andHAtypeIVcollagenexpression,whichmaybeanti-liverGankangkelioneofthemechanismsofliverfibrosis.Keywords:Gankangkeli；Liverfibrosis；TGF-β1；HA；IVcollagen；Serumradioimmunassay；ImmunohistochemistryAuthor：LiangfangTutor：Lichangqin中英文对照英文缩写HFECMCCl4英文全称HepaticfibrosisExtracelluarmatrixCarbontetrachioride中文全称肝纤维化细胞外基